AbbVie (NY:ABBV)

262.82 +2.89 (+1.11%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

99 100 Next >

Top S&P500 movers in Wednesday's session ↗

March 18, 2026

Via Chartmill

Wednesday's session: top gainers and losers in the S&P500 index ↗

March 18, 2026

Via Chartmill

What's Going On With AbbVie Stock Today? ↗

March 18, 2026

Shares of AbbVie Inc. (NASDAQ: ABBV) are moving lower Wednesday. The stock appears to be trending down after a competitor announced significant progress made on a treatment for plaque psoriasis.

Via Benzinga

Wednesday's session: gap up and gap down stock in the S&P500 index ↗

March 18, 2026

Via Chartmill

My Top 3 Dividend Kings to Buy for March 2026 ↗

March 17, 2026

Only the best dividend stocks can achieve "king" status.

Via The Motley Fool

ABBVIE INC (NYSE:ABBV) Shows Strong Technical Setup for Potential Breakout ↗

March 06, 2026

Via Chartmill

My 5 Favorite Dividend Stocks to Buy Right Now ↗

March 15, 2026

There are lots of choices, but these are at the top of my list.

Via The Motley Fool

Topics Retirement

Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities ↗

March 13, 2026

Howard Hughes owns large land holdings in fast-growing markets such as Las Vegas, Houston, and Phoenix, where it has developed master-planned communities over many years. Investors will watch whether...

Via The Motley Fool

Topics Regulatory Compliance

The Best Dividend Stocks to Buy and Hold Forever ↗

March 12, 2026

They are relatively safe wealth compounders.

Via The Motley Fool

Topics Intellectual Property

Market Downturn: 2 Stocks to Buy and Hold Through Any Storm ↗

March 11, 2026

These companies are highly unlikely to go under, no matter what happens.

Via The Motley Fool

Topics Intellectual Property

Quiet Outperformance From an Overlooked Dividend ETF ↗

March 09, 2026

Via MarketBeat

1 Momentum Stock to Consider Right Now and 2 We Ignore

March 09, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

These 3 Cash Flow Machines Provide Stability in Uncertain Markets ↗

March 06, 2026

Via MarketBeat

AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?

March 05, 2026

Over the past six months, AbbVie has been a great trade, beating the S&P 500 by 5.6%. Its stock price has climbed to $233.25, representing a healthy 11.2% in...

Via StockStory

Topics Stocks Supply Chain

AbbVie: The Only Big Pharma Stock I'd Consider a Buy‑and‑Never‑Sell ↗

March 04, 2026

Having successfully navigated the Humira patent cliff, AbbVie is poised for continued growth.

Via The Motley Fool

Topics Intellectual Property

Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive

March 03, 2026

As of March 3, 2026, Viatris Inc. (NASDAQ: VTRS) stands at a pivotal crossroads in its corporate evolution. Formed less than six years ago through one of the most complex healthcare mergers in recent...

Via Finterra

Topics Economy Initial Public Offering Retirement

Why AbbVie Stock May Be the Ultimate Option for Dividend Investors ↗

March 02, 2026

AbbVie pays a high dividend, has grown its payout regularly, and has a strong underlying business.

Via The Motley Fool

Topics Economy

Where Will AbbVie Be in 5 Years? ↗

February 26, 2026

The company is down slightly this year, but that may be a buying opportunity.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics

February 25, 2026

In a definitive move to dominate the next frontier of immunology and oncology, Eli Lilly and Company (NYSE: LLY) announced on February 9, 2026, its acquisition of Orna Therapeutics for a total...

Via MarketMinute

Topics Intellectual Property

Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises ↗

February 25, 2026

The company stated that, following the withdrawal of Gilgamesh’s challenge, there are no remaining challenges against its patent.

Via Stocktwits

Topics Intellectual Property

This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income ↗

February 24, 2026

AbbVie's dividend yield is far above the market's, and the dividend has been growing for years.

Via The Motley Fool

Topics ETFs Intellectual Property

Axsome Therapeutics (AXSM): A CNS Powerhouse at a Commercial Crossroad

February 23, 2026

As of February 23, 2026, the biotechnology landscape has shifted away from the speculative fervor of the early 2020s toward a demand for commercial execution and sustainable revenue. Standing at the...

Via Finterra

Topics Economy Initial Public Offering Intellectual Property

1 Cash-Producing Stock to Target This Week and 2 We Ignore

February 22, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

3 Stocks to Buy and Hold for 2026 and Beyond ↗

February 19, 2026

Any of these three pharmaceutical titans could move the needle in your portfolio.

Via The Motley Fool

Topics Economy Intellectual Property

2 Dividend Stocks to Hold for the Next 5 Years ↗

February 19, 2026

Income investors can rest easy owning these stocks.

Via The Motley Fool

Topics Energy Intellectual Property

What's going on in today's session: S&P500 movers ↗

February 18, 2026

Via Chartmill

6 Forever Dividend Stocks ↗

February 18, 2026

Cash Flowing Companies that Raise Dividends

Via The Motley Fool

1 Mega-Cap Stock on Our Watchlist and 2 We Avoid

February 17, 2026

Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works...

Via StockStory

8 Cheap Stocks to Buy in 2026 ↗

February 16, 2026

All 8 stocks with big upside

Via The Motley Fool

1 No-Brainer Dividend Stock to Buy on the Dip ↗

February 15, 2026

The recent dip may have been an overreaction.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.